Nuclear and cytoplasmatic subcellular fractioning of HCC cell lysates and subsequent Western blot analysis confirmed both nuclear and cytoplasmatic expression of PDE6D (Figure 6J). This evidence concerns the gene PDE6D and hepatocellular carcinoma.